{"id":2629,"date":"2007-04-04T12:00:30","date_gmt":"2007-04-04T11:00:30","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=2629"},"modified":"2013-09-20T17:42:58","modified_gmt":"2013-09-20T17:42:58","slug":"articles-from-aids-and-medscape","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/2629","title":{"rendered":"Articles from AIDS and Medscape"},"content":{"rendered":"<p><strong>AIDS Volume 21 Number 5 <\/strong><br \/>\n<strong><a href=\"http:\/\/www.medscape.com\/viewpublication\/744_index\">http:\/\/www.medscape.com\/viewpublication\/744_index<\/a><\/strong><\/p>\n<ul>\n<li>Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3\/HIV co-infected patients<\/li>\n<li>Efficacy and safety of TMC114\/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1<\/li>\n<li>Randomized trial of 2 simplified, class-sparing regimens for HIV after an initial 3- or 4-drug regimen<\/li>\n<li>Adherence in antiretroviral therapy for HIV: a review of qualitative studies<\/li>\n<\/ul>\n<h2>Summary of articles and other resources:<\/h2>\n<p>Summary of articles on clinical care <a href=\"http:\/\/www.medscape.com\/viewpublication\/880_index\"><br \/>\nhttp:\/\/www.medscape.com\/viewpublication\/880_index<\/a><\/p>\n<p>Long-term CD4 response: where you start predicts where you end up<\/p>\n<ul>\n<li>After 6 years of successful antiretroviral therapy for HIV, the only patients likely to achieve a low-to-normal CD4-cell count were those who had started treatment with CD4s &gt; 350.<\/li>\n<\/ul>\n<p>Successful antiretroviral therapy eliminates virus from the CSF<\/p>\n<ul>\n<li>New findings suggest that antiretroviral effects are magnified in the CNS.<\/li>\n<\/ul>\n<p>Routine testing for HIV infection: new CDC screening recommendations for the US population <a href=\"http:\/\/mp.medscape.com\/cgi-bin1\/DM\/y\/hBI8v0HC8BN0D1W0ILt70E6\"><br \/>\nhttp:\/\/mp.medscape.com\/cgi-bin1\/DM\/y\/hBI8v0HC8BN0D1W0ILt70E6<\/a><\/p>\n<p>Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients<br \/>\n<a href=\"http:\/\/mp.medscape.com\/cgi-bin1\/DM\/y\/hBI8h0HC8BN0D1P0ILvp0Ej\">http:\/\/mp.medscape.com\/cgi-bin1\/DM\/y\/hBI8h0HC8BN0D1P0ILvp0Ej<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AIDS Volume 21 Number 5 http:\/\/www.medscape.com\/viewpublication\/744_index Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3\/HIV co-infected patients Efficacy and safety of TMC114\/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 Randomized trial of &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-2629","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=2629"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2629\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=2629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=2629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=2629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}